Felix Renneberg

Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRINOX or Gemcitabine/nab-Paclitaxel.

Riedl, J. M., Schwarzenbacher, E., Moik, F., Horvath, L., Gantschnigg, A. (Co-author), Renneberg, F. (Co-author), Posch, F., Barth, D. A., Stotz, M., Pichler, M., Hatzl, S., Fandler-Höfler, S., Gressenberger, P., Gary, T., Jost, P. J., Greil, R. (Co-author), Ay, C., Djanani, A., Gerger, A. & Schlick, K. (Last author), 2022, In: THROMBOSIS AND HAEMOSTASIS . 122, 4, p. 633-645

Research output: Contribution to journal › Original Article › peer-review

Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis.

Riedl, J. M., Posch, F., Horvath, L., Gantschnigg, A. (Co-author), Renneberg, F. (Co-author), Schwarzenbacher, E., Moik, F., Barth, D. A., Rossmann, C. H., Stotz, M., Schaberl-Moser, R., Pichler, M., Stöger, H., Greil, R. (Co-author), Djanani, A., Schlick, K. (Co-author) & Gerger, A., 2021, In: EUROPEAN JOURNAL OF CANCER . 151, p. 3-13

Research output: Contribution to journal › Original Article › peer-review

FOLFIRINOX versus Gemcitabine/nabPaclitaxel as First-line palliative Therapy in advanced Pancreatic Cancer: a Propensity-Score Analysis

Riedl, J., Posch, F., Gantschnigg, A., Horvath, L., Renneberg, F., Schwarzenbacher, E., Moik, F., Barth, D., Stotz, M., Schaberl-Moser, R., Pichler, M., Stoger, H., Greil, R., Djanani, A., Schlick, K. & Gerger, A., 2020, In: WIENER KLINISCHE WOCHENSCHRIFT. 132, SUPPL 2, p. 78-79

Research output: Contribution to journal › Abstract (Journal) › peer-review

FOLFIRINOX versus Gemcitabine/nab-Paclitaxel as palliative first-line treatment of advanced pancreatic cancer: An Austrian observational Tri-Center comparative effectiveness analysis

Riedl, J., Posch, F., Horvath, L., Gantschnigg, A., Renneberg, F., Schwarzenbacher, E., Moik, F., Barth, D., Schaberl-Moser, R., Stotz, M., Pichler, M., Stoger, H., Greil, R., Djanani, A., Schlick, K. & Gerger, A., 2020, In: Oncology Research and Treatment. 43, SUPPL 4, p. 215-215

Research output: Contribution to journal › Abstract (Journal) › peer-review

Gemcitabine/nab-paclitaxel versus (modified) FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis

Riedl, J., Posch, F., Horvath, L., Gantschnigg, A., Renneberg, F., Schwarzenbacher, E., Moik, F., Barth, D., Stotz, M., Schaberl-Moser, R., Pichler, M., Stoger, H., Greil, R., Djanani, A., Schlick, K. & Gerger, A., 2020, In: ANNALS OF ONCOLOGY . 31, p. S942-S942

Research output: Contribution to journal › Abstract (Journal) › peer-review